Amundi
ANIP icon

Amundi’s ANI Pharmaceuticals ANIP Stock Holding History

Amundi’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Buy
31,793
+27,222
+596% +$2.18M ﹤0.01% 1118
2026
Q1 		$352K Sell
4,571
-61,159
-93% -$4.77M ﹤0.01% 1683
2025
Q4 		$5.19M Buy
65,730
+41,812
+175% +$3.62M ﹤0.01% 1028
2025
Q3 		$2.2M Buy
23,918
+285
+1% +$23.2K ﹤0.01% 1052
2025
Q2 		$1.54M Buy
+23,633
New +$1.54M ﹤0.01% 1133

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's ANIP Position: Q2 2026 in Review

Amundi increased its ANI Pharmaceuticals (ANIP) stake by 596% in Q2 2026, buying an estimated $2.18M and bringing the position to 31,793 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1118.

Amundi first reported a position in ANIP in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.19M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Amundi held 31,793 shares of ANI Pharmaceuticals worth $2.63M as of Q2 2026.
  • Amundi bought 27,222 ANI Pharmaceuticals shares in Q2 2026, an estimated $2.18M.
  • ANI Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1118 holding.
  • Amundi first reported a position in ANI Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Amundi's ANI Pharmaceuticals position peaked at $5.19M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.